Disposable Versus Reusable DrApes and Gowns for Green OperatiNg Theatres
Launched by UNIVERSITY OF BIRMINGHAM · Dec 1, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is comparing two types of surgical covers—disposable versus reusable drapes and gowns—to see which option is better at preventing infections after surgery. The study involves multiple hospitals and aims to determine if using disposable drapes and gowns is just as effective as using reusable ones when it comes to keeping patients safe from infections during and after surgery.
To participate in this trial, patients must be 10 years or older and have at least one surgical incision that is 5 centimeters or longer for adults, or 3 centimeters or longer for children under 16. This includes patients having both planned surgeries and emergency surgeries. If a patient has a smaller incision or is undergoing a procedure that is considered clean (not likely to cause infection), they won't be eligible for this trial. Participants can expect to be randomly assigned to either the disposable or reusable group, and their recovery will be monitored to see how well each option helps prevent infections. This trial is currently recruiting participants, so there is an opportunity for eligible patients to contribute to important research in surgical safety.
Gender
ALL
Eligibility criteria
- Inclusion criteria:
- • Patients with at least one incision that is ≥5cm in adults and ≥3cm in children aged under 16 years. This can include both open and minimally-invasive surgery providing at least one incision meets this criteria.
- • Patients with a clean-contaminated, contaminated, or dirty surgical wound. Definitions of contamination are given in Table 2.
- • Patients undergoing emergency (surgery on an unplanned admission) or elective (surgery on a planned admission) surgery.
- • Any operative indication (including caesarean section).
- • Patients aged 10 or over.
- • Exclusion criteria
- • Adults with an incision \<5 cm and incision \<3cm in children aged under 16 years.
- • Patients undergoing procedures with a clean surgical wound only.
About University Of Birmingham
The University of Birmingham is a leading research institution in the UK, renowned for its commitment to advancing medical science and improving health outcomes through innovative clinical research. With a strong emphasis on collaboration, the university engages in multidisciplinary studies that leverage cutting-edge technology and expertise across various fields. Its dedicated clinical trial infrastructure supports rigorous investigation and the ethical conduct of research, ensuring that findings contribute meaningfully to the scientific community and public health. Through its initiatives, the University of Birmingham aims to translate research discoveries into tangible benefits for patients and healthcare systems alike.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Guadalajara, , Mexico
Patients applied
Trial Officials
Aneel Bhangu
Principal Investigator
University of Birmingham
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported